Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
about
Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasiaDominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicityInteraction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsCripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cellsDistribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor familyAnalysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interfaceInhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domainWnt signalling via the epidermal growth factor receptor: a role in breast cancer?Knowledge Gaps in Rodent Pancreas Biology: Taking Human Pluripotent Stem Cell-Derived Pancreatic Beta Cells into Our Own HandsSolution structure of the mEGF/TGFalpha44-50 chimeric growth factorDefects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4The ErbB signaling network: receptor heterodimerization in development and cancerDermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage.Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal womanHER/ErbB receptor interactions and signaling patterns in human mammary epithelial cellsThe type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer.c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.The role of endogenous epidermal growth factor receptor ligands in mediating corneal epithelial homeostasis.Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases.HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo.Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy.Two EGF molecules contribute additively to stabilization of the EGFR dimerErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.Bivalence of EGF-like ligands drives the ErbB signaling networkDifferential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependencyHer4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion.Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progressionIdentification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.Expression of NRG1 and its receptors in human bladder cancer.Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancerDefective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.
P2860
Q22009058-C02C8973-DAE5-44A6-896F-4FFCBBBFF14BQ22010838-62694C1E-C882-4F5F-842F-F7833E2A55BDQ22254244-15F31B09-DC2F-4FBE-9280-A6C50B72DA85Q24316433-E2A3854E-6433-4074-9985-928101727860Q24319040-B986436C-B3F2-47D9-AFA7-39555E455821Q24319261-F6F834A4-19F9-4EB9-9D9B-C6D9A48F8DD8Q24336447-804F3178-8148-4AA2-9C6E-7D9686770D7EQ24522643-EB459CFE-8CD4-41C6-ABA0-8AD38ED42539Q24529941-D4897BA4-48F5-4876-AF28-64E6EA8740FDQ24551173-6907A3B2-A00E-4F4A-9856-4A866B73826CQ24794064-A6031D35-83F7-4BCA-A1DD-E2538243EC16Q26772748-CBC9BB67-A797-4916-A626-7415C6F9CD88Q27636565-E1B03D86-A121-4FFE-A2D1-C0D3DB16F685Q28506344-04328E80-FEB7-47B5-ADE3-BEC720EBE33AQ29617919-9107A3C9-214D-445A-88F8-1BFFB1A722CFQ31111797-1A52CBB5-1B12-4229-A0D1-A80710B53062Q33346629-7A1A26F5-0614-41BF-A10E-62D36BAAF7B1Q33514127-8F067ABC-A457-4849-A3D2-FB937CFE6EEDQ33538424-4345C593-63E6-48DC-A3BF-9A033E399B45Q33538427-85F3D50D-9D61-44A6-8D17-4A4E9EACF06BQ33558517-4813F137-36ED-4C7F-A4A1-DECB27CC07B8Q33700160-B22BE6A7-8C38-40F1-852A-8DE059996506Q33708436-9BD10948-B072-4A21-B3DB-E9A8010DCF18Q33765924-EB5078BD-7201-49F3-AD68-4C0123EBEB92Q33801908-4CE5FC22-0BE6-490A-B649-8ECC1337DBD4Q33859549-0358E4A1-AF35-4BBA-98E3-A5D8E98AA3BFQ33885990-4E736CEC-4F86-4A95-8BB5-F8158CC72D32Q33886341-4821A013-DE17-467B-A5F6-2137CB25C0A7Q33887274-D3725E47-DBAD-4A82-91D8-F59C24525903Q33888963-7535B820-EB5A-4628-B7EB-F8CB72B36D2DQ33963261-C65144A9-FD7C-45C2-A1BB-4673AA5D992EQ33968565-6AC7111B-A807-4F01-B277-8D44F3BFEE40Q34122915-10B65E75-4922-4272-A6ED-644E787B8B9EQ34130669-B74984C0-7BAD-4552-B301-83A243E08DF3Q34212116-A0675803-BC59-4004-8231-AF36668C8B9EQ34304234-382D0ED4-47F8-4047-8B88-3368A6B5B299Q34563226-4B46E549-E45F-4A52-8A67-5E6801A64BA1Q34745805-288DC3C4-0F71-4D85-A85D-0F6B471CF42BQ35007438-A28A27D0-38B4-4A1F-8D13-B84EBA5337C7Q35032897-99534E5D-8F51-4A2C-A6F1-C26B42B63B8F
P2860
Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Epidermal growth factor-relate ...... n their biological activities.
@en
type
label
Epidermal growth factor-relate ...... n their biological activities.
@en
prefLabel
Epidermal growth factor-relate ...... n their biological activities.
@en
P2860
P356
P1476
Epidermal growth factor-relate ...... n their biological activities.
@en
P2093
P2860
P304
P356
10.1074/JBC.271.11.6071
P407
P577
1996-03-01T00:00:00Z